Product Information
METRONIDAZOLE 250 MG TABLET is a generic product labeled by Method Pharmaceuticals LLC, priced at $0.1068 per EA under NDC 58657093301. Its NADAC has been published 37 times since Dec 10, 2025.
FDA first approved this application on Jul 16, 1986. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Method Pharmaceuticals LLCNDC
58657093301
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METRONIDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA070772FDA Approved
7/16/1986
TE Code
AB
On Market Since
7/1/2025
Pharmacological Classes
Price Statistics
The NADAC for METRONIDAZOLE 250 MG TABLET has been published 37 times since Dec 10, 2025, and over the history we have for it it has risen 47.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1068 per EA |
|---|---|
| All-time high | $0.1070 (Aug 12, 2026) |
| All-time low | $0.0623 (Dec 17, 2025) |
| 52-week high | $0.1070 |
| 52-week low | $0.0623 |
| Median price | $0.0725 |
| Average price | $0.0805 |
| Largest weekly change | +20.1% (Jun 17, 2026) |
| Weeks tracked | 37 |
| Tracking since | Dec 10, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METRONIDAZOLE 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE 250 MG TABLET, manufactured by Method Pharmaceuticals LLC, is $0.1068 per EA (NDC 58657093301), effective Aug 19, 2026.
How has the price of METRONIDAZOLE 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for METRONIDAZOLE 250 MG TABLET has risen 47.4%. It has been tracked across 37 weekly CMS publications since Dec 10, 2025.
What are the highest and lowest recorded NADAC prices for METRONIDAZOLE 250 MG TABLET?
Since Dec 10, 2025, the NADAC for METRONIDAZOLE 250 MG TABLET has ranged from a low of $0.0623 (Dec 17, 2025) to a high of $0.1070 (Aug 12, 2026), with a median of $0.0725 per EA.
Are there cheaper alternatives to METRONIDAZOLE 250 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METRONIDAZOLE 250 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METRONIDAZOLE 250 MG TABLET?
METRONIDAZOLE 250 MG TABLET (NDC 58657093301) is labeled by Method Pharmaceuticals LLC, and CMS classifies it as a generic product.